

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 8.84827118 |
| 2 | cellular response to ATP (GO:0071318) | 8.79981619 |
| 3 | negative regulation of cell aging (GO:0090344) | 8.51793794 |
| 4 | DNA strand renaturation (GO:0000733) | 8.31966910 |
| 5 | GDP-mannose metabolic process (GO:0019673) | 7.30153641 |
| 6 | mitotic cell cycle arrest (GO:0071850) | 7.15345275 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.84976074 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 6.84976074 |
| 9 | regulation of synapse structural plasticity (GO:0051823) | 6.83949021 |
| 10 | transepithelial transport (GO:0070633) | 6.52202334 |
| 11 | meiotic chromosome segregation (GO:0045132) | 6.51012786 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.45605819 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 6.45605819 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 6.14555353 |
| 15 | lens fiber cell differentiation (GO:0070306) | 5.99200079 |
| 16 | detection of light stimulus involved in visual perception (GO:0050908) | 5.94240647 |
| 17 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.94240647 |
| 18 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 5.77781301 |
| 19 | adenosine receptor signaling pathway (GO:0001973) | 5.76198695 |
| 20 | tryptophan catabolic process (GO:0006569) | 5.54119729 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 5.54119729 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 5.54119729 |
| 23 | tryptophan metabolic process (GO:0006568) | 5.36155109 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.30642824 |
| 25 | bile acid biosynthetic process (GO:0006699) | 5.28463451 |
| 26 | kynurenine metabolic process (GO:0070189) | 5.19007636 |
| 27 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 5.17441730 |
| 28 | * protein carboxylation (GO:0018214) | 5.17441730 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.15425808 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 5.13439771 |
| 31 | glyoxylate metabolic process (GO:0046487) | 5.12078533 |
| 32 | complement activation, alternative pathway (GO:0006957) | 5.10917783 |
| 33 | estrogen biosynthetic process (GO:0006703) | 5.09989112 |
| 34 | regulation of fibrinolysis (GO:0051917) | 5.09750354 |
| 35 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.04653123 |
| 36 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.00356454 |
| 37 | alpha-linolenic acid metabolic process (GO:0036109) | 4.93733491 |
| 38 | rRNA methylation (GO:0031167) | 4.92671415 |
| 39 | urea metabolic process (GO:0019627) | 4.86726332 |
| 40 | urea cycle (GO:0000050) | 4.86726332 |
| 41 | regulation of complement activation (GO:0030449) | 4.85123280 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.82259228 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.75823867 |
| 44 | behavioral response to nicotine (GO:0035095) | 4.69848331 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 4.68966151 |
| 46 | bile acid metabolic process (GO:0008206) | 4.58141234 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.54878576 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 4.53565809 |
| 49 | positive regulation of heat generation (GO:0031652) | 4.47512445 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 4.43572018 |
| 51 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.43401021 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.40245994 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.39940551 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.39940551 |
| 55 | response to ATP (GO:0033198) | 4.33856073 |
| 56 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.31616549 |
| 57 | cysteine metabolic process (GO:0006534) | 4.31413227 |
| 58 | reverse cholesterol transport (GO:0043691) | 4.30524092 |
| 59 | rRNA modification (GO:0000154) | 4.29824442 |
| 60 | purine ribonucleotide transport (GO:0015868) | 4.29779003 |
| 61 | heme transport (GO:0015886) | 4.26143076 |
| 62 | positive regulation of protein kinase C signaling (GO:0090037) | 4.23172594 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 4.19751518 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 4.16454814 |
| 65 | macromolecular complex remodeling (GO:0034367) | 4.16454814 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 4.16454814 |
| 67 | regulation of triglyceride catabolic process (GO:0010896) | 4.16285678 |
| 68 | nucleotide transmembrane transport (GO:1901679) | 4.13823734 |
| 69 | serine family amino acid catabolic process (GO:0009071) | 4.12486844 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 4.10989593 |
| 71 | peristalsis (GO:0030432) | 4.10291059 |
| 72 | regulation of cell aging (GO:0090342) | 4.10204992 |
| 73 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.09512760 |
| 74 | bile acid and bile salt transport (GO:0015721) | 4.08149969 |
| 75 | amino-acid betaine metabolic process (GO:0006577) | 4.05996685 |
| 76 | coenzyme catabolic process (GO:0009109) | 4.03462713 |
| 77 | alpha-amino acid catabolic process (GO:1901606) | 4.03293911 |
| 78 | phospholipid efflux (GO:0033700) | 3.98026959 |
| 79 | plasma lipoprotein particle clearance (GO:0034381) | 3.96772647 |
| 80 | imidazole-containing compound metabolic process (GO:0052803) | 3.95662850 |
| 81 | sphingomyelin metabolic process (GO:0006684) | 3.89769489 |
| 82 | nucleoside transmembrane transport (GO:1901642) | 3.88402241 |
| 83 | cellular glucuronidation (GO:0052695) | 3.88328159 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 3.86794844 |
| 85 | amine catabolic process (GO:0009310) | 3.86794844 |
| 86 | cholesterol efflux (GO:0033344) | 3.85700476 |
| 87 | cellular ketone body metabolic process (GO:0046950) | 3.84327375 |
| 88 | fibrinolysis (GO:0042730) | 3.83397369 |
| 89 | lysine metabolic process (GO:0006553) | 3.83380607 |
| 90 | lysine catabolic process (GO:0006554) | 3.83380607 |
| 91 | phosphate ion homeostasis (GO:0055062) | 3.81473581 |
| 92 | trivalent inorganic anion homeostasis (GO:0072506) | 3.81473581 |
| 93 | type B pancreatic cell proliferation (GO:0044342) | 3.81232258 |
| 94 | phosphate ion transmembrane transport (GO:0035435) | 3.78000154 |
| 95 | cellular amino acid catabolic process (GO:0009063) | 3.72725853 |
| 96 | granulocyte differentiation (GO:0030851) | 3.71494935 |
| 97 | adenine nucleotide transport (GO:0051503) | 3.68269725 |
| 98 | iron coordination entity transport (GO:1901678) | 3.64261874 |
| 99 | cellular anion homeostasis (GO:0030002) | 3.63127103 |
| 100 | benzene-containing compound metabolic process (GO:0042537) | 3.62791876 |
| 101 | sphingosine metabolic process (GO:0006670) | 3.61907027 |
| 102 | negative regulation of protein activation cascade (GO:2000258) | 3.61338815 |
| 103 | semaphorin-plexin signaling pathway (GO:0071526) | 3.60825963 |
| 104 | sensory perception of taste (GO:0050909) | 3.59757482 |
| 105 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.59669060 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.59335950 |
| 107 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.59165990 |
| 108 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.59165990 |
| 109 | negative regulation of sterol transport (GO:0032372) | 3.57639420 |
| 110 | negative regulation of cholesterol transport (GO:0032375) | 3.57639420 |
| 111 | plasma lipoprotein particle assembly (GO:0034377) | 3.55698697 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 3.53692214 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.52750239 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 3.51261061 |
| 115 | glutamate metabolic process (GO:0006536) | 3.49593672 |
| 116 | complement activation (GO:0006956) | 3.47726601 |
| 117 | protein activation cascade (GO:0072376) | 3.47580110 |
| 118 | regulation of heat generation (GO:0031650) | 3.47333712 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.47319682 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.47319682 |
| 121 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.46989252 |
| 122 | complement activation, classical pathway (GO:0006958) | 3.46778034 |
| 123 | blood coagulation, intrinsic pathway (GO:0007597) | 3.46215992 |
| 124 | opsonization (GO:0008228) | 3.45937435 |
| 125 | ketone body metabolic process (GO:1902224) | 3.44449306 |
| 126 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44010496 |
| 127 | diol metabolic process (GO:0034311) | 3.43878039 |
| 128 | cholesterol homeostasis (GO:0042632) | 3.43098414 |
| 129 | urinary tract smooth muscle contraction (GO:0014848) | 3.42894529 |
| 130 | glucuronate metabolic process (GO:0019585) | 3.42527489 |
| 131 | uronic acid metabolic process (GO:0006063) | 3.42527489 |
| 132 | lipoprotein metabolic process (GO:0042157) | 3.41538292 |
| 133 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.39014826 |
| 134 | regulation of cholesterol homeostasis (GO:2000188) | 3.38395795 |
| 135 | organic acid catabolic process (GO:0016054) | 3.37848888 |
| 136 | carboxylic acid catabolic process (GO:0046395) | 3.37848888 |
| 137 | purinergic receptor signaling pathway (GO:0035587) | 3.37315212 |
| 138 | sterol homeostasis (GO:0055092) | 3.37246846 |
| 139 | regulation of plasminogen activation (GO:0010755) | 3.36655812 |
| 140 | drug catabolic process (GO:0042737) | 3.34030184 |
| 141 | arginine metabolic process (GO:0006525) | 3.31521011 |
| 142 | regulation of bile acid biosynthetic process (GO:0070857) | 3.30844172 |
| 143 | folic acid metabolic process (GO:0046655) | 3.30088439 |
| 144 | intestinal cholesterol absorption (GO:0030299) | 3.29891778 |
| 145 | positive regulation of lipid catabolic process (GO:0050996) | 3.29623069 |
| 146 | glycine metabolic process (GO:0006544) | 3.28979848 |
| 147 | purine nucleotide transport (GO:0015865) | 3.28908862 |
| 148 | fatty acid oxidation (GO:0019395) | 3.28833698 |
| 149 | fatty acid beta-oxidation (GO:0006635) | 3.28336952 |
| 150 | monocarboxylic acid catabolic process (GO:0072329) | 3.27710055 |
| 151 | cytolysis (GO:0019835) | 3.27159597 |
| 152 | DNA replication checkpoint (GO:0000076) | 3.25438414 |
| 153 | cofactor catabolic process (GO:0051187) | 3.24848258 |
| 154 | plasma lipoprotein particle organization (GO:0071827) | 3.24455166 |
| 155 | short-chain fatty acid metabolic process (GO:0046459) | 3.23930727 |
| 156 | UV protection (GO:0009650) | 3.22497858 |
| 157 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.20153935 |
| 158 | proline metabolic process (GO:0006560) | 3.17974747 |
| 159 | melanin biosynthetic process (GO:0042438) | 3.17223302 |
| 160 | alkaloid metabolic process (GO:0009820) | 3.17148171 |
| 161 | negative regulation of interleukin-8 production (GO:0032717) | 3.17094124 |
| 162 | phosphate ion transport (GO:0006817) | 3.08718811 |
| 163 | proline biosynthetic process (GO:0006561) | 3.08180392 |
| 164 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.07811970 |
| 165 | cardiolipin metabolic process (GO:0032048) | 3.07780217 |
| 166 | sphingoid metabolic process (GO:0046519) | 3.06474451 |
| 167 | estrogen metabolic process (GO:0008210) | 3.04349070 |
| 168 | mannose metabolic process (GO:0006013) | 3.03778545 |
| 169 | respiratory chain complex IV assembly (GO:0008535) | 2.97318229 |
| 170 | exogenous drug catabolic process (GO:0042738) | 2.93491814 |
| 171 | sex determination (GO:0007530) | 2.93107089 |
| 172 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.92434375 |
| 173 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.90294017 |
| 174 | grooming behavior (GO:0007625) | 2.90154944 |
| 175 | secondary metabolite biosynthetic process (GO:0044550) | 2.88110401 |
| 176 | oligosaccharide catabolic process (GO:0009313) | 2.84071326 |
| 177 | glutathione derivative biosynthetic process (GO:1901687) | 2.80676670 |
| 178 | glutathione derivative metabolic process (GO:1901685) | 2.80676670 |
| 179 | androgen biosynthetic process (GO:0006702) | 2.78889615 |
| 180 | endocytic recycling (GO:0032456) | 2.75393398 |
| 181 | nucleoside transport (GO:0015858) | 2.75159866 |
| 182 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.74080902 |
| 183 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.74080902 |
| 184 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.74080902 |
| 185 | response to gravity (GO:0009629) | 2.73077611 |
| 186 | melanin metabolic process (GO:0006582) | 2.70162020 |
| 187 | negative regulation of digestive system process (GO:0060457) | 2.70050271 |
| 188 | folic acid transport (GO:0015884) | 2.69242804 |
| 189 | neuromuscular synaptic transmission (GO:0007274) | 2.66014863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.21305015 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.05990863 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.99335633 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.83551442 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.59071454 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.37997808 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.98656265 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.96282733 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.82908597 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.72335050 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.23715128 |
| 12 | P68_20966046_ChIP-Seq_HELA_Human | 3.13320915 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.02013268 |
| 14 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.99396205 |
| 15 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.96309294 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.75371683 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.64035324 |
| 18 | * E2F1_20622854_ChIP-Seq_HELA_Human | 2.60995898 |
| 19 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.45142074 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42991770 |
| 21 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.33919190 |
| 22 | BCOR_27268052_Chip-Seq_Bcells_Human | 2.33408264 |
| 23 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.33394716 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 2.32981422 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.29994019 |
| 26 | PHF8_20622854_ChIP-Seq_HELA_Human | 2.29063377 |
| 27 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.28744602 |
| 28 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 2.27291540 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09712103 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.05855396 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.02521342 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0641118 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99748045 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95053312 |
| 35 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.94745999 |
| 36 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.94541723 |
| 37 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.93834676 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93500189 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.93240057 |
| 40 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.92908457 |
| 41 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.85535871 |
| 42 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.84112483 |
| 43 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.82702730 |
| 44 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.82511080 |
| 45 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.81558352 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.81445317 |
| 47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80722585 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.77509794 |
| 49 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.76421233 |
| 50 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.75567505 |
| 51 | ERA_21632823_ChIP-Seq_H3396_Human | 1.71199399 |
| 52 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.70757426 |
| 53 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.67370998 |
| 54 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66625732 |
| 55 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.66031355 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.63276583 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61040761 |
| 58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.60376506 |
| 59 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60304654 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.56920852 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.55740479 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.54484701 |
| 63 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.52100551 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51347973 |
| 65 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.48676805 |
| 66 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.44172667 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42690022 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41215544 |
| 69 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.39321049 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37631528 |
| 71 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.36009848 |
| 72 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34066554 |
| 73 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.31388066 |
| 74 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 1.30936208 |
| 75 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30620302 |
| 76 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27977879 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27138602 |
| 78 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.25987896 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25417784 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25417784 |
| 81 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.23216228 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23073092 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21739001 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21726575 |
| 85 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.20754476 |
| 86 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.19739567 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19396555 |
| 88 | P300_27268052_Chip-Seq_Bcells_Human | 1.19309697 |
| 89 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.19083099 |
| 90 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18985568 |
| 91 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.18830724 |
| 92 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17524296 |
| 93 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.17083787 |
| 94 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15072168 |
| 95 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.14865992 |
| 96 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.14384415 |
| 97 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.13891252 |
| 98 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13252146 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11946605 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09688138 |
| 101 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08861589 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.07428852 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07404491 |
| 104 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06790555 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06745187 |
| 106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05940149 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05048001 |
| 108 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.04611133 |
| 109 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04120882 |
| 110 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03881648 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03752219 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03001218 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01949513 |
| 114 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00743769 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00436535 |
| 116 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98628881 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98215316 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97974447 |
| 119 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97566106 |
| 120 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97228661 |
| 121 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.97133440 |
| 122 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.96889250 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96857640 |
| 124 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95999385 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95581124 |
| 126 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95140731 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93586263 |
| 128 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89825939 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89713774 |
| 130 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89274788 |
| 131 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88947357 |
| 132 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88226591 |
| 133 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87243447 |
| 134 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86956682 |
| 135 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86948614 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84641329 |
| 137 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82766687 |
| 138 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81727837 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81506938 |
| 140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81023518 |
| 141 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80716744 |
| 142 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.79554834 |
| 143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76412912 |
| 144 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75708165 |
| 145 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75569602 |
| 146 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.74541188 |
| 147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74381169 |
| 148 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71895166 |
| 149 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68907128 |
| 150 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68828840 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66876441 |
| 152 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.63314999 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.63311827 |
| 154 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62100453 |
| 155 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.61284887 |
| 156 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.59078876 |
| 157 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.58996969 |
| 158 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.57899825 |
| 159 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.57899825 |
| 160 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57511652 |
| 161 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.57415857 |
| 162 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.57107587 |
| 163 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.56747863 |
| 164 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56588949 |
| 165 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.55870892 |
| 166 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55689147 |
| 167 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.54631732 |
| 168 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.54560912 |
| 169 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.54244912 |
| 170 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.54066791 |
| 171 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53909032 |
| 172 | GATA1_19941826_ChIP-Seq_K562_Human | 0.53194035 |
| 173 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.53157408 |
| 174 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52181434 |
| 175 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.50336381 |
| 176 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.50127092 |
| 177 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.49745154 |
| 178 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.48884565 |
| 179 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48551938 |
| 180 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.48303987 |
| 181 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.47335215 |
| 182 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.47147143 |
| 183 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.46960648 |
| 184 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.46867337 |
| 185 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.46408892 |
| 186 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.46397049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 7.54973754 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.42644683 |
| 3 | MP0005360_urolithiasis | 6.27328060 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.83217278 |
| 5 | MP0005365_abnormal_bile_salt | 5.78294900 |
| 6 | MP0001986_abnormal_taste_sensitivity | 5.64002826 |
| 7 | MP0005174_abnormal_tail_pigmentation | 5.45114462 |
| 8 | MP0005423_abnormal_somatic_nervous | 4.99907931 |
| 9 | MP0003136_yellow_coat_color | 4.79093231 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 4.19713706 |
| 11 | MP0003252_abnormal_bile_duct | 3.86432234 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 3.41227479 |
| 13 | MP0003195_calcinosis | 3.33617137 |
| 14 | MP0010329_abnormal_lipoprotein_level | 3.29430307 |
| 15 | MP0005083_abnormal_biliary_tract | 2.88408680 |
| 16 | MP0005409_darkened_coat_color | 2.61259178 |
| 17 | MP0000751_myopathy | 2.57660179 |
| 18 | MP0009840_abnormal_foam_cell | 2.54482848 |
| 19 | MP0001188_hyperpigmentation | 2.46473240 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.45880388 |
| 21 | MP0005332_abnormal_amino_acid | 2.40480598 |
| 22 | MP0002160_abnormal_reproductive_system | 2.24492430 |
| 23 | MP0002638_abnormal_pupillary_reflex | 2.22557396 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.20944768 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.07861239 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 2.04695490 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 2.04039884 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.97864730 |
| 29 | MP0005330_cardiomyopathy | 1.95542692 |
| 30 | MP0000609_abnormal_liver_physiology | 1.91202431 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.88125593 |
| 32 | MP0001502_abnormal_circadian_rhythm | 1.87845709 |
| 33 | MP0003868_abnormal_feces_composition | 1.86493082 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.84170494 |
| 35 | MP0009697_abnormal_copulation | 1.73928689 |
| 36 | MP0002736_abnormal_nociception_after | 1.73535630 |
| 37 | MP0000538_abnormal_urinary_bladder | 1.73111041 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.69740411 |
| 39 | MP0001764_abnormal_homeostasis | 1.68994067 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.62139800 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.54931506 |
| 42 | MP0005410_abnormal_fertilization | 1.51111638 |
| 43 | MP0005670_abnormal_white_adipose | 1.46887541 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.44495309 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.44055863 |
| 46 | MP0005408_hypopigmentation | 1.42358745 |
| 47 | MP0005220_abnormal_exocrine_pancreas | 1.36967570 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.35970631 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.33722996 |
| 50 | MP0001919_abnormal_reproductive_system | 1.29437059 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.28300567 |
| 52 | MP0005503_abnormal_tendon_morphology | 1.27951568 |
| 53 | MP0005275_abnormal_skin_tensile | 1.20737844 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18595032 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.16147892 |
| 56 | MP0005647_abnormal_sex_gland | 1.10549363 |
| 57 | MP0003724_increased_susceptibility_to | 1.10285988 |
| 58 | MP0001324_abnormal_eye_pigmentation | 1.09900512 |
| 59 | MP0005501_abnormal_skin_physiology | 1.08175078 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.07765608 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 1.06513818 |
| 62 | MP0003878_abnormal_ear_physiology | 1.05009918 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.05009918 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.04942025 |
| 65 | MP0004381_abnormal_hair_follicle | 1.03075816 |
| 66 | MP0000013_abnormal_adipose_tissue | 1.02750163 |
| 67 | MP0000598_abnormal_liver_morphology | 1.02748679 |
| 68 | MP0002735_abnormal_chemical_nociception | 1.01523850 |
| 69 | MP0005389_reproductive_system_phenotype | 0.99972224 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 0.98246280 |
| 71 | MP0002909_abnormal_adrenal_gland | 0.94682648 |
| 72 | MP0000747_muscle_weakness | 0.91509561 |
| 73 | MP0003279_aneurysm | 0.91210336 |
| 74 | MP0003186_abnormal_redox_activity | 0.91195952 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.90677095 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.89723511 |
| 77 | MP0005253_abnormal_eye_physiology | 0.88318241 |
| 78 | MP0009764_decreased_sensitivity_to | 0.86725016 |
| 79 | MP0005451_abnormal_body_composition | 0.86048163 |
| 80 | MP0002254_reproductive_system_inflammat | 0.85982705 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.85593498 |
| 82 | MP0009763_increased_sensitivity_to | 0.84935795 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.84217817 |
| 84 | MP0002295_abnormal_pulmonary_circulatio | 0.83346338 |
| 85 | MP0000470_abnormal_stomach_morphology | 0.82803924 |
| 86 | MP0002060_abnormal_skin_morphology | 0.81393414 |
| 87 | MP0001944_abnormal_pancreas_morphology | 0.81362123 |
| 88 | MP0001661_extended_life_span | 0.81092229 |
| 89 | MP0002928_abnormal_bile_duct | 0.80031342 |
| 90 | MP0005334_abnormal_fat_pad | 0.79540063 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.78284284 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.77529803 |
| 93 | MP0002971_abnormal_brown_adipose | 0.76941219 |
| 94 | MP0000367_abnormal_coat/_hair | 0.76085306 |
| 95 | MP0004272_abnormal_basement_membrane | 0.75671321 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 0.74464444 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.73880974 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.73163472 |
| 99 | MP0003011_delayed_dark_adaptation | 0.73010288 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.71981767 |
| 101 | MP0008469_abnormal_protein_level | 0.71613968 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.71134001 |
| 103 | MP0001756_abnormal_urination | 0.70348518 |
| 104 | MP0001664_abnormal_digestion | 0.69573147 |
| 105 | MP0002168_other_aberrant_phenotype | 0.69030188 |
| 106 | MP0005535_abnormal_body_temperature | 0.67822050 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.67160116 |
| 108 | MP0003690_abnormal_glial_cell | 0.65912085 |
| 109 | MP0006054_spinal_hemorrhage | 0.64663575 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.64350943 |
| 111 | MP0001243_abnormal_dermal_layer | 0.63923278 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.63241008 |
| 113 | MP0003718_maternal_effect | 0.62987849 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.62516416 |
| 115 | MP0004043_abnormal_pH_regulation | 0.62490911 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.61740542 |
| 117 | MP0004130_abnormal_muscle_cell | 0.60284426 |
| 118 | MP0010771_integument_phenotype | 0.59744085 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.59437755 |
| 120 | MP0003077_abnormal_cell_cycle | 0.58524867 |
| 121 | MP0003953_abnormal_hormone_level | 0.58174788 |
| 122 | MP0005448_abnormal_energy_balance | 0.56446320 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.56247578 |
| 124 | MP0000358_abnormal_cell_content/ | 0.55555439 |
| 125 | MP0003315_abnormal_perineum_morphology | 0.55213238 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.55021087 |
| 127 | MP0001542_abnormal_bone_strength | 0.53417806 |
| 128 | MP0001905_abnormal_dopamine_level | 0.52687020 |
| 129 | MP0004883_abnormal_blood_vessel | 0.52536704 |
| 130 | MP0000003_abnormal_adipose_tissue | 0.52475920 |
| 131 | MP0005164_abnormal_response_to | 0.51898116 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.51748760 |
| 133 | MP0003959_abnormal_lean_body | 0.51119464 |
| 134 | MP0005395_other_phenotype | 0.50723551 |
| 135 | MP0001958_emphysema | 0.49635859 |
| 136 | MP0005023_abnormal_wound_healing | 0.49601688 |
| 137 | MP0002933_joint_inflammation | 0.49240432 |
| 138 | MP0002108_abnormal_muscle_morphology | 0.47458247 |
| 139 | MP0004197_abnormal_fetal_growth/weight/ | 0.47254856 |
| 140 | MP0000249_abnormal_blood_vessel | 0.46755546 |
| 141 | MP0002075_abnormal_coat/hair_pigmentati | 0.45896532 |
| 142 | MP0000566_synostosis | 0.45574550 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.45388581 |
| 144 | MP0009931_abnormal_skin_appearance | 0.45338052 |
| 145 | MP0010386_abnormal_urinary_bladder | 0.45299394 |
| 146 | MP0001879_abnormal_lymphatic_vessel | 0.44759915 |
| 147 | MP0003632_abnormal_nervous_system | 0.43942437 |
| 148 | MP0004264_abnormal_extraembryonic_tissu | 0.43656806 |
| 149 | MP0006138_congestive_heart_failure | 0.43633840 |
| 150 | MP0004957_abnormal_blastocyst_morpholog | 0.43324035 |
| 151 | MP0008770_decreased_survivor_rate | 0.41955822 |
| 152 | MP0000604_amyloidosis | 0.41942125 |
| 153 | MP0005195_abnormal_posterior_eye | 0.41629967 |
| 154 | MP0001191_abnormal_skin_condition | 0.41254601 |
| 155 | MP0008872_abnormal_physiological_respon | 0.40638687 |
| 156 | MP0001348_abnormal_lacrimal_gland | 0.38922448 |
| 157 | MP0003448_altered_tumor_morphology | 0.38827683 |
| 158 | MP0005076_abnormal_cell_differentiation | 0.37768228 |
| 159 | MP0005391_vision/eye_phenotype | 0.36835469 |
| 160 | MP0001346_abnormal_lacrimal_gland | 0.36471376 |
| 161 | MP0002210_abnormal_sex_determination | 0.35505413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.72952274 |
| 2 | Testicular atrophy (HP:0000029) | 6.67206380 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.63560412 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.57691594 |
| 5 | Rib fusion (HP:0000902) | 6.38039314 |
| 6 | * Prolonged partial thromboplastin time (HP:0003645) | 6.21459162 |
| 7 | Xanthomatosis (HP:0000991) | 5.83587348 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.71293777 |
| 9 | Dyschromatopsia (HP:0007641) | 5.55280822 |
| 10 | Mesangial abnormality (HP:0001966) | 5.54438146 |
| 11 | Attenuation of retinal blood vessels (HP:0007843) | 5.48306548 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.32310889 |
| 13 | Complement deficiency (HP:0004431) | 5.17170065 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 5.14615920 |
| 15 | Rectovaginal fistula (HP:0000143) | 5.04145910 |
| 16 | Rectal fistula (HP:0100590) | 5.04145910 |
| 17 | Hypoglycemic coma (HP:0001325) | 4.87701539 |
| 18 | Vaginal fistula (HP:0004320) | 4.72637547 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 4.65236681 |
| 20 | Popliteal pterygium (HP:0009756) | 4.63705900 |
| 21 | Poikiloderma (HP:0001029) | 4.55431473 |
| 22 | Intestinal fistula (HP:0100819) | 4.54468324 |
| 23 | Lipid accumulation in hepatocytes (HP:0006561) | 4.46611968 |
| 24 | * Abnormality of the common coagulation pathway (HP:0010990) | 4.46211428 |
| 25 | Facial diplegia (HP:0001349) | 4.43548611 |
| 26 | Renal Fanconi syndrome (HP:0001994) | 4.42382804 |
| 27 | * Joint hemorrhage (HP:0005261) | 4.35125625 |
| 28 | Ulnar bowing (HP:0003031) | 4.30394065 |
| 29 | Akinesia (HP:0002304) | 4.29660629 |
| 30 | Ketosis (HP:0001946) | 4.24568501 |
| 31 | Thin bony cortex (HP:0002753) | 4.24214914 |
| 32 | Facial hemangioma (HP:0000329) | 4.16665928 |
| 33 | Aplasia of the musculature (HP:0100854) | 4.15002168 |
| 34 | * Abnormality of the intrinsic pathway (HP:0010989) | 4.14109966 |
| 35 | Hypolipoproteinemia (HP:0010981) | 4.11505848 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 4.06626598 |
| 37 | Hypoglycemic seizures (HP:0002173) | 4.06266622 |
| 38 | Coronal craniosynostosis (HP:0004440) | 4.04013026 |
| 39 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.03053246 |
| 40 | Epidermoid cyst (HP:0200040) | 4.02041179 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.01006011 |
| 42 | Congenital stationary night blindness (HP:0007642) | 4.00703785 |
| 43 | Fat malabsorption (HP:0002630) | 3.92443445 |
| 44 | Choroideremia (HP:0001139) | 3.90441384 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 3.83994106 |
| 46 | Annular pancreas (HP:0001734) | 3.82905072 |
| 47 | Abnormality of complement system (HP:0005339) | 3.73785515 |
| 48 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.72253049 |
| 49 | Ketoacidosis (HP:0001993) | 3.71985796 |
| 50 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.71137087 |
| 51 | Decreased central vision (HP:0007663) | 3.70625757 |
| 52 | Turricephaly (HP:0000262) | 3.68582390 |
| 53 | Hyperammonemia (HP:0001987) | 3.68021664 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 3.60758922 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.60090231 |
| 56 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.58468053 |
| 57 | Hyperglycinemia (HP:0002154) | 3.57196261 |
| 58 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.55446113 |
| 59 | Fetal akinesia sequence (HP:0001989) | 3.48371072 |
| 60 | Abnormal albumin level (HP:0012116) | 3.45908122 |
| 61 | Hypoalbuminemia (HP:0003073) | 3.45908122 |
| 62 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.43177799 |
| 63 | Chorioretinal atrophy (HP:0000533) | 3.43000220 |
| 64 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.42856930 |
| 65 | Hyperglycinuria (HP:0003108) | 3.40509988 |
| 66 | Amniotic constriction ring (HP:0009775) | 3.30274886 |
| 67 | Abnormality of placental membranes (HP:0011409) | 3.30274886 |
| 68 | Atrioventricular block (HP:0001678) | 3.29096451 |
| 69 | Abnormality of glycine metabolism (HP:0010895) | 3.23504176 |
| 70 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.23504176 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 3.23431436 |
| 72 | Patellar aplasia (HP:0006443) | 3.18828603 |
| 73 | Squamous cell carcinoma (HP:0002860) | 3.18448113 |
| 74 | Delayed epiphyseal ossification (HP:0002663) | 3.15858465 |
| 75 | Short chin (HP:0000331) | 3.14662675 |
| 76 | Hypercholesterolemia (HP:0003124) | 3.14104820 |
| 77 | Skin nodule (HP:0200036) | 3.10812586 |
| 78 | Symptomatic seizures (HP:0011145) | 3.09580944 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.09397904 |
| 80 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.08703062 |
| 81 | Myotonia (HP:0002486) | 3.02772426 |
| 82 | Hyperbilirubinemia (HP:0002904) | 3.01344182 |
| 83 | Increased intramyocellular lipid droplets (HP:0012240) | 3.01152658 |
| 84 | Exertional dyspnea (HP:0002875) | 3.00222273 |
| 85 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.95383252 |
| 86 | Anteriorly placed anus (HP:0001545) | 2.94805707 |
| 87 | Myocardial infarction (HP:0001658) | 2.90570066 |
| 88 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.90408941 |
| 89 | Increased muscle lipid content (HP:0009058) | 2.87853591 |
| 90 | Hyperglycemia (HP:0003074) | 2.83694470 |
| 91 | Abnormality of the costochondral junction (HP:0000919) | 2.82747131 |
| 92 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.82214824 |
| 93 | Steatorrhea (HP:0002570) | 2.76307354 |
| 94 | Mitral stenosis (HP:0001718) | 2.76275734 |
| 95 | Zonular cataract (HP:0010920) | 2.74916601 |
| 96 | Neonatal respiratory distress (HP:0002643) | 2.73939297 |
| 97 | Enlarged kidneys (HP:0000105) | 2.70529467 |
| 98 | Vascular calcification (HP:0004934) | 2.70153465 |
| 99 | Abnormal urine phosphate concentration (HP:0012599) | 2.69394645 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 2.69299127 |
| 101 | Systemic lupus erythematosus (HP:0002725) | 2.69005199 |
| 102 | Cardiovascular calcification (HP:0011915) | 2.66752176 |
| 103 | Enlarged epiphyses (HP:0010580) | 2.65367298 |
| 104 | Spontaneous abortion (HP:0005268) | 2.63975653 |
| 105 | Abnormality of purine metabolism (HP:0004352) | 2.62841278 |
| 106 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.60619971 |
| 107 | Capillary hemangiomas (HP:0005306) | 2.60128068 |
| 108 | Abnormality of renal resorption (HP:0011038) | 2.59200527 |
| 109 | Delayed CNS myelination (HP:0002188) | 2.55838167 |
| 110 | Gout (HP:0001997) | 2.53338242 |
| 111 | Widely patent fontanelles and sutures (HP:0004492) | 2.51577320 |
| 112 | Joint stiffness (HP:0001387) | 2.50959499 |
| 113 | Respiratory difficulties (HP:0002880) | 2.46850143 |
| 114 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.45181650 |
| 115 | Generalized aminoaciduria (HP:0002909) | 2.43102782 |
| 116 | Bowed forearm bones (HP:0003956) | 2.42283401 |
| 117 | Bowing of the arm (HP:0006488) | 2.42283401 |
| 118 | Abnormality of serum amino acid levels (HP:0003112) | 2.41543205 |
| 119 | Late onset (HP:0003584) | 2.40193820 |
| 120 | Metabolic acidosis (HP:0001942) | 2.39416178 |
| 121 | Glomerulonephritis (HP:0000099) | 2.38114331 |
| 122 | Absent thumb (HP:0009777) | 2.37482246 |
| 123 | Choanal stenosis (HP:0000452) | 2.37201188 |
| 124 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.34597252 |
| 125 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.34597252 |
| 126 | Increased number of teeth (HP:0011069) | 2.34093151 |
| 127 | Glycosuria (HP:0003076) | 2.29991518 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 2.29991518 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29556961 |
| 130 | Dicarboxylic aciduria (HP:0003215) | 2.29556961 |
| 131 | Renal cortical cysts (HP:0000803) | 2.26859296 |
| 132 | Hypochromic microcytic anemia (HP:0004840) | 2.26510637 |
| 133 | Pterygium (HP:0001059) | 2.24576922 |
| 134 | Short humerus (HP:0005792) | 2.19962514 |
| 135 | Opisthotonus (HP:0002179) | 2.16268165 |
| 136 | Reduced antithrombin III activity (HP:0001976) | 2.16186573 |
| 137 | Renal tubular dysfunction (HP:0000124) | 2.13836104 |
| 138 | Menorrhagia (HP:0000132) | 2.13204147 |
| 139 | Pancreatitis (HP:0001733) | 2.10338158 |
| 140 | Birth length less than 3rd percentile (HP:0003561) | 2.09766171 |
| 141 | Gingival bleeding (HP:0000225) | 2.08957200 |
| 142 | Narrow nasal bridge (HP:0000446) | 2.06998919 |
| 143 | Diminished movement (HP:0002374) | 2.06843704 |
| 144 | Hyperphosphaturia (HP:0003109) | 2.04916983 |
| 145 | Esophageal varix (HP:0002040) | 2.04618169 |
| 146 | Acanthocytosis (HP:0001927) | 2.03925540 |
| 147 | Thin ribs (HP:0000883) | 2.03757360 |
| 148 | Premature graying of hair (HP:0002216) | 2.03660808 |
| 149 | Protrusio acetabuli (HP:0003179) | 2.03101674 |
| 150 | Abnormal gallbladder morphology (HP:0012437) | 2.03025793 |
| 151 | Macular degeneration (HP:0000608) | 2.02777088 |
| 152 | Malignant hyperthermia (HP:0002047) | 2.02316678 |
| 153 | Abnormal drinking behavior (HP:0030082) | 2.02146910 |
| 154 | Polydipsia (HP:0001959) | 2.02146910 |
| 155 | Lethargy (HP:0001254) | 2.00610924 |
| 156 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.99882286 |
| 157 | Heart block (HP:0012722) | 1.97360405 |
| 158 | Absent radius (HP:0003974) | 1.96846401 |
| 159 | Flat occiput (HP:0005469) | 1.93846204 |
| 160 | Long clavicles (HP:0000890) | 1.93256031 |
| 161 | Abnormal cartilage morphology (HP:0002763) | 1.92933103 |
| 162 | Sensorimotor neuropathy (HP:0007141) | 1.92812390 |
| 163 | Abnormality of the hepatic vasculature (HP:0006707) | 1.92291167 |
| 164 | Pendular nystagmus (HP:0012043) | 1.90886704 |
| 165 | Biconcave vertebral bodies (HP:0004586) | 1.90095472 |
| 166 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89777898 |
| 167 | Amyloidosis (HP:0011034) | 1.89384720 |
| 168 | Hydroxyprolinuria (HP:0003080) | 1.88481240 |
| 169 | Abnormality of proline metabolism (HP:0010907) | 1.88481240 |
| 170 | Protuberant abdomen (HP:0001538) | 1.87119368 |
| 171 | Irritability (HP:0000737) | 1.87016706 |
| 172 | Cerebral palsy (HP:0100021) | 1.85870323 |
| 173 | Abnormal atrioventricular conduction (HP:0005150) | 1.85542998 |
| 174 | Absent forearm bone (HP:0003953) | 1.85335655 |
| 175 | Aplasia involving forearm bones (HP:0009822) | 1.85335655 |
| 176 | Hypoplasia of the pons (HP:0012110) | 1.82598128 |
| 177 | Nonimmune hydrops fetalis (HP:0001790) | 1.82534110 |
| 178 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81076515 |
| 179 | Cerebral edema (HP:0002181) | 1.79731955 |
| 180 | Thrombophlebitis (HP:0004418) | 1.79422227 |
| 181 | Elevated alkaline phosphatase (HP:0003155) | 1.78992607 |
| 182 | Cholelithiasis (HP:0001081) | 1.78058200 |
| 183 | Cheilitis (HP:0100825) | 1.78008121 |
| 184 | Rickets (HP:0002748) | 1.76956721 |
| 185 | Brushfield spots (HP:0001088) | 1.76756537 |
| 186 | Hemorrhage of the eye (HP:0011885) | 1.76013539 |
| 187 | Hypophosphatemic rickets (HP:0004912) | 1.75711959 |
| 188 | Type 2 muscle fiber atrophy (HP:0003554) | 1.75469489 |
| 189 | Small hand (HP:0200055) | 1.74822055 |
| 190 | Proximal tubulopathy (HP:0000114) | 1.74138111 |
| 191 | Insulin resistance (HP:0000855) | 1.73626195 |
| 192 | Nephritis (HP:0000123) | 1.73260537 |
| 193 | Vomiting (HP:0002013) | 1.72936469 |
| 194 | Neonatal onset (HP:0003623) | 1.72839881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.35664893 |
| 2 | INSRR | 4.93543674 |
| 3 | BCKDK | 4.17534531 |
| 4 | MUSK | 4.11933758 |
| 5 | SIK1 | 3.74090168 |
| 6 | TIE1 | 3.48286321 |
| 7 | ERN1 | 3.20373842 |
| 8 | TLK1 | 3.12493874 |
| 9 | TAOK3 | 3.09767461 |
| 10 | FGFR4 | 3.02746651 |
| 11 | STK16 | 2.93552943 |
| 12 | MAPK15 | 2.76991790 |
| 13 | BLK | 2.41551951 |
| 14 | FRK | 2.30077517 |
| 15 | MST1R | 2.24511665 |
| 16 | IRAK3 | 2.14275218 |
| 17 | PIK3CG | 2.03070259 |
| 18 | TGFBR2 | 2.03066026 |
| 19 | FLT3 | 1.99846396 |
| 20 | ADRBK2 | 1.89334070 |
| 21 | LATS1 | 1.88966384 |
| 22 | ACVR1B | 1.83001437 |
| 23 | NEK9 | 1.76859695 |
| 24 | AKT3 | 1.74153327 |
| 25 | ADRBK1 | 1.70169177 |
| 26 | ERBB4 | 1.69904861 |
| 27 | BMPR1B | 1.53858637 |
| 28 | WNK1 | 1.45353868 |
| 29 | TESK2 | 1.44503453 |
| 30 | MET | 1.41687241 |
| 31 | PTK6 | 1.39003813 |
| 32 | TRIB3 | 1.35026928 |
| 33 | EPHA3 | 1.30671249 |
| 34 | CAMK1D | 1.30461998 |
| 35 | FGFR2 | 1.26517934 |
| 36 | PINK1 | 1.23958048 |
| 37 | STK39 | 1.21205758 |
| 38 | KDR | 1.17806178 |
| 39 | CCNB1 | 1.16600800 |
| 40 | PKN2 | 1.15653610 |
| 41 | SIK2 | 1.14669457 |
| 42 | JAK1 | 1.14593060 |
| 43 | GRK1 | 1.13714623 |
| 44 | PDGFRA | 1.13527629 |
| 45 | MAPK11 | 1.10155708 |
| 46 | IRAK1 | 1.07030639 |
| 47 | PRKAA2 | 1.05994552 |
| 48 | NEK2 | 1.05174554 |
| 49 | TYK2 | 1.04653569 |
| 50 | DYRK1B | 1.03304229 |
| 51 | PDPK1 | 1.01394673 |
| 52 | ZAK | 0.99562763 |
| 53 | STK38L | 0.97953068 |
| 54 | TRIM28 | 0.97139801 |
| 55 | SGK2 | 0.97117074 |
| 56 | GRK6 | 0.94094201 |
| 57 | CDK6 | 0.92064020 |
| 58 | CDK15 | 0.91842300 |
| 59 | MAP3K3 | 0.91237315 |
| 60 | OXSR1 | 0.89527318 |
| 61 | PDK2 | 0.88840466 |
| 62 | CDK4 | 0.88680914 |
| 63 | NUAK1 | 0.88022069 |
| 64 | MAP2K6 | 0.86788029 |
| 65 | MAP2K3 | 0.85616422 |
| 66 | CDK18 | 0.85176168 |
| 67 | MYLK | 0.82787127 |
| 68 | CDK11A | 0.82754191 |
| 69 | SGK3 | 0.81758623 |
| 70 | MAP2K4 | 0.81063991 |
| 71 | PTK2 | 0.81034506 |
| 72 | JAK2 | 0.79588245 |
| 73 | EPHB2 | 0.78453307 |
| 74 | MAPK7 | 0.78230110 |
| 75 | CAMK1G | 0.78180887 |
| 76 | PRKD2 | 0.74772581 |
| 77 | PIK3CA | 0.73526524 |
| 78 | TEC | 0.73251616 |
| 79 | GSK3A | 0.71767193 |
| 80 | FGFR3 | 0.71470606 |
| 81 | MELK | 0.68029759 |
| 82 | MAP3K14 | 0.67847377 |
| 83 | MAP2K2 | 0.66308678 |
| 84 | NLK | 0.66258043 |
| 85 | PRKAA1 | 0.63900968 |
| 86 | BMX | 0.63596352 |
| 87 | EPHB1 | 0.63577316 |
| 88 | IGF1R | 0.61996553 |
| 89 | FER | 0.61899351 |
| 90 | PAK1 | 0.61673032 |
| 91 | TRPM7 | 0.61285925 |
| 92 | TGFBR1 | 0.59147595 |
| 93 | MAP3K7 | 0.57991213 |
| 94 | PLK1 | 0.57954192 |
| 95 | SGK494 | 0.57718722 |
| 96 | SGK223 | 0.57718722 |
| 97 | CSNK1D | 0.57594999 |
| 98 | WNK3 | 0.57223830 |
| 99 | ABL2 | 0.57025457 |
| 100 | CHEK2 | 0.56654255 |
| 101 | AURKA | 0.56403106 |
| 102 | CDK14 | 0.54442649 |
| 103 | GRK7 | 0.54241475 |
| 104 | PRKCE | 0.53939610 |
| 105 | ERBB2 | 0.53846253 |
| 106 | PASK | 0.53349883 |
| 107 | TBK1 | 0.52800420 |
| 108 | IRAK2 | 0.52763318 |
| 109 | STK11 | 0.52333963 |
| 110 | PRKACG | 0.51655477 |
| 111 | BRAF | 0.50596096 |
| 112 | RIPK1 | 0.50040154 |
| 113 | PHKG2 | 0.49733312 |
| 114 | PHKG1 | 0.49733312 |
| 115 | GRK5 | 0.48704324 |
| 116 | CHUK | 0.47283728 |
| 117 | IKBKE | 0.46455070 |
| 118 | DDR2 | 0.45944011 |
| 119 | BRSK2 | 0.45476463 |
| 120 | RPS6KA6 | 0.45221672 |
| 121 | MAP3K1 | 0.44653141 |
| 122 | HIPK2 | 0.44628046 |
| 123 | OBSCN | 0.44162014 |
| 124 | MTOR | 0.42769252 |
| 125 | ATR | 0.42670351 |
| 126 | PAK3 | 0.42124855 |
| 127 | PRKCH | 0.39860927 |
| 128 | ZAP70 | 0.39709935 |
| 129 | PRKD1 | 0.39419044 |
| 130 | IRAK4 | 0.39286086 |
| 131 | CAMK4 | 0.38807116 |
| 132 | CAMK2G | 0.38103593 |
| 133 | RPS6KA2 | 0.36735784 |
| 134 | MAPK8 | 0.36486655 |
| 135 | PRKCZ | 0.36286520 |
| 136 | MAP2K1 | 0.35859866 |
| 137 | EIF2AK2 | 0.35684556 |
| 138 | MAPK4 | 0.35343316 |
| 139 | MAPKAPK3 | 0.34954049 |
| 140 | DAPK2 | 0.34866069 |
| 141 | EPHA2 | 0.34078052 |
| 142 | MAPK12 | 0.34064834 |
| 143 | MAP3K6 | 0.33789170 |
| 144 | RPS6KA5 | 0.33379095 |
| 145 | PIM2 | 0.33208368 |
| 146 | CSK | 0.32788334 |
| 147 | PRKCQ | 0.31797530 |
| 148 | IKBKB | 0.31093497 |
| 149 | PRKCG | 0.29336417 |
| 150 | DYRK2 | 0.29314999 |
| 151 | PRKACA | 0.27944222 |
| 152 | STK38 | 0.26567943 |
| 153 | PRKCA | 0.23925989 |
| 154 | RPS6KL1 | 0.23027540 |
| 155 | RPS6KC1 | 0.23027540 |
| 156 | CDK1 | 0.22068590 |
| 157 | PBK | 0.20125487 |
| 158 | ARAF | 0.17037842 |
| 159 | BUB1 | 0.15742305 |
| 160 | PRKCD | 0.15010495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40772850 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.14746593 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.12028260 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.06821053 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.91312008 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.85799593 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78102301 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72058403 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52013164 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51477282 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48096052 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.37643599 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.36144327 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24360355 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20776317 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18895286 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.16204927 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12804846 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.11773400 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08045743 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96439316 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88582093 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88028520 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87879621 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87575338 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80569130 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80364512 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.78402036 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77434686 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69484962 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67401289 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65689317 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60707847 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60658801 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56570628 |
| 36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.56068772 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.55340092 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53258791 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52816137 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49794171 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49626269 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.45965502 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.44157100 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.38756469 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35640001 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28879585 |
| 47 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.26364656 |
| 48 | * Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25519986 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19725425 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18630807 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15604224 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10233650 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07201017 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99794194 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.97418458 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 0.96895091 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94257455 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94155666 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93814635 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93471195 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.90748463 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88792962 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87144255 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87027002 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84604404 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84281289 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80639452 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76007080 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.69290693 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67277124 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62361866 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60722860 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59210948 |
| 74 | Protein export_Homo sapiens_hsa03060 | 0.58675644 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58590995 |
| 76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57884895 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56767462 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54921205 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.54193517 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.53098516 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51576467 |
| 82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50458767 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50401485 |
| 84 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50023724 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49042891 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48899578 |
| 87 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48133984 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46332033 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.45022262 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44536909 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42173931 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.41765689 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40044572 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38500912 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35211078 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34438595 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30708035 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30390463 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.29829557 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27190036 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24348622 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24290781 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23696454 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22778843 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21650054 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21395881 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21213943 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20960802 |
| 109 | Base excision repair_Homo sapiens_hsa03410 | 0.20450840 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19957223 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.16633439 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.16293678 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11558262 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.11116108 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.07736409 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.06755595 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.06015744 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04921256 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04833825 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04237450 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04201024 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01007682 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.00036512 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0420724 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0418036 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | -0.0357838 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0297144 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0249056 |

